Showing 1 - 20 results of 24 for search 'Mark R Litzow', query time: 0.05s
Refine Results
-
1
Management of toxicities associated with novel immunotherapy agents in acute lymphoblastic leukemia by Tania Jain, Mark R. Litzow
Published 2020-01-01
Article -
2
-
3
Calr type 1/like mutation in myelofibrosis is the most prominent predictor of momelotinib drug survival and longevity without transplant by Ayalew Tefferi, Animesh Pardanani, Kebede H. Begna, Aref Al-Kali, William J. Hogan, Mark R. Litzow, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat
Published 2024-03-01
Article -
4
Chronic phase CML with sole P190 (e1a2) BCR::ABL1: long-term outcome among ten consecutive cases by Maymona G. Abdelmagid, Mark R. Litzow, Kristen B. McCullough, Naseema Gangat, Animesh Pardanani, Hemant S. Murthy, James M. Foran, Rhett P. Ketterling, David Viswanatha, Kebede H. Begna, Ayalew Tefferi
Published 2022-07-01
Article -
5
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity by Talha Badar, Yenny A. Moreno Vanegas, Ahmad Nanaa, James M. Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B. Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R. Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M. Patnaik
Published 2023-09-01
Article -
6
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome by Aref Al-Kali, Ahmad Nanaa, David Viswanatha, Rong He, Phuong Nguyen, Dragan Jevremovic, James M. Foran, Cecelia Arana Yi, Patricia T. Greipp, Naseema Gangat, Mrinal Patnaik, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Talha Badar, Hassan B. Alkhateeb
Published 2023-04-01
Article -
7
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma by Ricardo D. Parrondo, Zaid Abdel Rahman, Michael G. Heckman, Mikolaj Wieczorek, Liuyan Jiang, Hassan B. Alkhateeb, Mark R. Litzow, Patricia Greipp, Taimur Sher, Leif Bergsagel, Rafael Fonseca, Vivek Roy, Angela Dispenzieri, Mohamed A. Kharfan-Dabaja, Hemant S. Murthy, Sikander Ailawadhi, James M. Foran
Published 2022-06-01
Article -
8
Therapy-related clonal cytopenia as a precursor to therapy-related myeloid neoplasms by Mithun Vinod Shah, Abhishek A. Mangaonkar, Kebede H. Begna, Hassan B. Alkhateeb, Patricia Greipp, Ahmad Nanaa, Michelle A. Elliott, William J. Hogan, Mark R. Litzow, Kristen McCullough, Ayalew Tefferi, Naseema Gangat, Mrinal M. Patnaik, Aref Al-Kali, Rong He, Dong Chen
Published 2022-07-01
Article -
9
High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphoma by José A. Fernández-Gutiérrez, Oscar A. Reyes-Cisneros, Mark R. Litzow, Lorena Bojalil-Álvarez, Elizabeth García-Villaseñor, Eliezer Tomas Gómez-Gomez, Iván Murrieta-Álvarez, David Gomez-Almaguer, Cesar H. Gutierrez-Aguirre, Amado J. Karduss-Urueta, Guillermo J. Ruiz-Delgado, Guillermo José Ruiz-Argüelles
Published 2022-12-01
Article -
10
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the C... by Talha Badar, Ahmad Nanaa, Ehab Atallah, Rory M. Shallis, Sacchi de Camargo Correia Guilherme, Aaron D. Goldberg, Antoine N. Saliba, Anand Patel, Jan P. Bewersdorf, Adam S. DuVall, Danielle Bradshaw, Yasmin Abaza, Guru Subramanian Guru Murthy, Neil Palmisiano, Amer M. Zeidan, Vamsi Kota, Mark R. Litzow
Published 2024-02-01
Article -
11
Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma by Hassan B. Alkhateeb, Razan Mohty, Patricia Greipp, Radhika Bansal, Matthew Hathcock, Allison Rosenthal, Hemant Murthy, Mohamed Kharfan-Dabaja, Jose C. Bisneto Villasboas, Nora Bennani, Stephen M. Ansell, Mrinal M. Patnaik, Mark R. Litzow, Rong He, Dong Chen, Aref Al-Kali, Saad S. Kenderian, Yi Lin, Mithun Vinod Shah
Published 2022-07-01
Article -
12
Mayo Clinic experience with 1123 adults with acute myeloid leukemia by Kebede H. Begna, Walid Ali, Naseema Gangat, Michelle A. Elliott, Aref Al-Kali, Mark R. Litzow, C. Christopher Hook, Alexandra P. Wolanskyj-Spinner, William J. Hogan, Mrinal M. Patnaik, Animesh Pardanani, Darci L. Zblewski, Dong Chen, Rong He, David Viswanatha, Curtis A. Hanson, Rhett P. Ketterling, Ayalew Tefferi
Published 2021-03-01
Article -
13
Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia by Beth A. Pitel, Cinthya Zepeda-Mendoza, Zohar Sachs, Hongwei Tang, Suganti Shivaram, Neeraj Sharma, James B. Smadbeck, Stephanie A. Smoley, Kathryn E. Pearce, Ivy M. Luoma, Joselle Cook, Mark R. Litzow, Nicole L. Hoppman, David Viswanatha, Xinjie Xu, Rhett P. Ketterling, Patricia T. Greipp, Jess F. Peterson, Linda B. Baughn
Published 2023-09-01
Article -
14
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation by Maansi Joshi, Joselle Cook, Kristen McCullough, Ahmad Nanaa, Naseema Gangat, James M. Foran, Hemant S. Murthy, Mohamed A. Kharfan-Dabaja, Lisa Sproat, Jeanne Palmer, Animesh Pardanani, Ayalew Tefferi, Kebede Begna, Michelle Elliot, Aref Al-Kali, Mrinal Patnaik, Mithun V. Shah, William J. Hogan, Mark R. Litzow, Hassan B. Alkhateeb
Published 2021-03-01
Article -
15
Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review. by Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen
Published 2021-01-01
Article -
16
Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusiv... by Maymona G. Abdelmagid, Aref Al-Kali, Mark R. Litzow, Kebede H. Begna, William J. Hogan, Mirinal S. Patnaik, Shahrukh K. Hashmi, Michelle A. Elliott, Hassan Alkhateeb, Omer S. Karrar, Farah Fleti, Mohammed H. Elnayir, Candido E. Rivera, Hemant S. Murthy, James M. Foran, Mohamed A. Kharfan-Dabaja, Talha Badar, David S. Viswanatha, Kaaren K. Reichard, Naseema Gangat, Ayalew Tefferi
Published 2023-08-01
Article -
17
Protein lysine 43 methylation by EZH1 promotes AML1-ETO transcriptional repression in leukemia by Liping Dou, Fei Yan, Jiuxia Pang, Dehua Zheng, Dandan Li, Li Gao, Lijun Wang, Yihan Xu, Jinlong Shi, Qian Wang, Lei Zhou, Na Shen, Puja Singh, Lili Wang, Yonghui Li, Yvchi Gao, Tao Liu, Chongjian Chen, Aref Al-Kali, Mark R. Litzow, Young-In Chi, Ann M. Bode, Chunhui Liu, Haojie Huang, Daihong Liu, Guido Marcucci, Shujun Liu, Li Yu
Published 2019-11-01
Article -
18
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients by Rong He, Jonathan Chiou, Allison Chiou, Dong Chen, Constance P. Chen, Caroline Spethman, Kurt R. Bessonen, Jennifer L. Oliveira, Phuong L. Nguyen, Kaaren K. Reichard, James D. Hoyer, Simon D. Althoff, Dana J. Roh, Mechelle A. Miller, Ji Yuan, Horatiu Olteanu, Kebede Begna, Ayalew Tefferi, Hassan Alkhateeb, Mrinal M. Patnaik, Mark R. Litzow, Aref Al-Kali, David S. Viswanatha
Published 2022-01-01
Article -
19
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) by Mostafa Abdallah, Kristen McCullough, Rimal Ilyas, Kebede H. Begna, Aref Al-Kali, Mark R. Litzow, William J. Hogan, Abhishek Mangaonkar, Hassan Alkhateeb, Mithun V. Shah, Michelle A. Elliott, James M. Foran, Talha Badar, Jeanne M. Palmer, Cecilia Arana Yi, Lisa Sproat, Animesh Pardanani, Mrinal M. Patnaik, Horatiu Olteanu, Rhett P. Ketterling, Ayalew Tefferi, Naseema Gangat
Published 2023-03-01
Article -
20
Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes by Zaid H. Abdel-Rahman, Michael G. Heckman, Theodora Anagnostou, Launia J. White, Sara M. Kloft‐Nelson, Ryan A. Knudson, Hassan B. Alkhateeb, Lisa Z. Sproat, Nandita Khera, Hemant S. Murthy, Ernesto Ayala, William J. Hogan, Vivek Roy, Jess F. Peterson, Mohamed A. Kharfan-Dabaja, Rhett P. Ketterling, Mark R. Litzow, Linda B. Baughn, Mrinal Patnaik, Patricia T. Greipp, James M. Foran
Published 2021-09-01
Article